Serum from patients with hypertension promotes endothelial dysfunction to induce trophoblast invasion through the miR‑27b‑3p/ATPase plasma membrane Ca<sup>2+</sup> transporting 1 axis

Zhu,Libo; Liu,Zhuqing

doi:10.3892/mmr.2021.11958

Serum from patients with hypertension promotes endothelial dysfunction to induce trophoblast invasion through the miR‑27b‑3p/ATPase plasma membrane Ca²⁺ transporting 1 axis

Authors:
- Libo Zhu
- Zhuqing Liu
View Affiliations

Affiliations: Department of Obstetrics, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310006, P.R. China
Published online on: March 3, 2021 https://doi.org/10.3892/mmr.2021.11958
Article Number: 319
Copyright: © Zhu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Pregnancy‑induced hypertension is often accompanied by preeclampsia. The present study investigated whether microRNA (miR)‑27b‑3p affected the occurrence of preeclampsia by regulating the function of endothelial cells. Expressions levels of miR‑27b‑3p and ATPase plasma membrane Ca²⁺ transporting 1 (ATP2B1) were determined using reverse‑transcription quantitative PCR. miR‑27b‑3p targeting ATP2B1 was predicted using bioinformatics and further confirmed by dual‑luciferase reporter assays. Cell Counting Kit‑8, Transwell and Matrigel tube formation assays were performed to detect the effects of miR‑27b‑3p on proliferation, migration and tube formation of human umbilical vein endothelial cells (HUVECs), respectively. Moreover, HTR8/SVneos cells were co‑cultured with HUVECs to detect the invasion of trophoblast cells, and the expression levels of vascular endothelial growth factor (VEGF), matrix metalloproteinase (MMP)‑2 and MMP‑9 of HUVECs and HTR8/SVneos were detected by western blotting. Expression levels of miR‑27b‑3p were upregulated in the serum of patients with hypertension and preeclampsia, which could target and regulate the expression of ATP2B1. The expression levels of miR‑27b‑3p were increased and those of ATP2B1 were reduced in HUVECs from hypertensive serums. Moreover, miR‑27b‑3p mimics reduced the expression level of ATP2B1, and miR‑27b‑3p inhibitor reversed the effect of hypertensive serum on ATP2B1 expression. Furthermore, patients with hypertension showed increased endothelial dysfunction, reduced trophoblastic invasion and the expressions of VEGF, MMP‑2 and MMP‑9, and miR‑27b‑3p mimics and silencing of ATP2B1 produced similar results to HUVECs. The miR‑27b‑3p inhibitor reversed the effect of hypertensive serum, and silencing of ATP2B1 inhibited the improvement of miR‑27b‑3p inhibitor to HUVECs and HTR‑8/SVneo cells in proliferation, migration and tube formation. The current findings suggested that miR‑27b‑3p promoted proliferation, migration and tube formation of HUVECs and enhanced invasion of trophoblast cells, via regulation of ATP2B1. Thus, miR‑27b‑3p could be considered as a molecular risk factor in the pathogenesis and development of preeclampsia.

View Figures

View References

1	Alrahmani L and Willrich MAV: The complement alternative pathway and preeclampsia. Curr Hypertens Rep. 20:402018. View Article : Google Scholar : PubMed/NCBI
2	Steegers EA, von Dadelszen P, Duvekot JJ and Pijnenborg R: Pre-eclampsia. Lancet. 376:631–644. 2010. View Article : Google Scholar : PubMed/NCBI
3	Kelly RS, Giorgio RT, Chawes BL, Palacios NI, Gray KJ, Mirzakhani H, Wu A, Blighe K, Weiss ST and Lasky-Su J: Applications of metabolomics in the study and management of preeclampsia: A review of the literature. Metabolomics. 13:132017. View Article : Google Scholar
4	Seely EW and Maxwell C: Cardiology patient page. Chronic hypertension in pregnancy. Circulation. 115:e188–e190. 2007. View Article : Google Scholar : PubMed/NCBI
5	Tabara Y, Kohara K and Miki T; Millennium Genome Project for Hypertension, : Hunting for genes for hypertension: The Millennium Genome Project for Hypertension. Hypertens Res. 35:567–573. 2012. View Article : Google Scholar : PubMed/NCBI
6	Tabara Y, Kohara K, Kita Y, Hirawa N, Katsuya T, Ohkubo T, Hiura Y, Tajima A, Morisaki T, Miyata T, et al Global Blood Pressure Genetics Consortium, : Common variants in the ATP2B1 gene are associated with susceptibility to hypertension: The Japanese Millennium Genome Project. Hypertension. 56:973–980. 2010. View Article : Google Scholar : PubMed/NCBI
7	Cho YS, Go MJ, Kim YJ, Heo JY, Oh JH, Ban HJ, Yoon D, Lee MH, Kim DJ, Park M, et al: A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet. 41:527–534. 2009. View Article : Google Scholar : PubMed/NCBI
8	Kohara K, Tabara Y, Nakura J, Imai Y, Ohkubo T, Hata A, Soma M, Nakayama T, Umemura S, Hirawa N, et al: Identification of hypertension-susceptibility genes and pathways by a systemic multiple candidate gene approach: The millennium genome project for hypertension. Hypertens Res. 31:203–212. 2008. View Article : Google Scholar : PubMed/NCBI
9	Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A, Glazer NL, Morrison AC, Johnson AD, Aspelund T, et al: Genome-wide association study of blood pressure and hypertension. Nat Genet. 41:677–687. 2009. View Article : Google Scholar : PubMed/NCBI
10	Wang Y, Zhang Y, Li Y, Zhou X, Wang X, Gao P, Jin L, Zhang X and Zhu D: Common variants in the ATP2B1 gene are associated with hypertension and arterial stiffness in Chinese population. Mol Biol Rep. 40:1867–1873. 2013. View Article : Google Scholar : PubMed/NCBI
11	Doridot L, Houry D, Gaillard H, Chelbi ST, Barbaux S and Vaiman D: miR-34a expression, epigenetic regulation, and function in human placental diseases. Epigenetics. 9:142–151. 2014. View Article : Google Scholar : PubMed/NCBI
12	Wang Y, Fan H, Zhao G, Liu D, Du L, Wang Z, Hu Y and Hou Y: miR-16 inhibits the proliferation and angiogenesis-regulating potential of mesenchymal stem cells in severe pre-eclampsia. FEBS J. 279:4510–4524. 2012. View Article : Google Scholar : PubMed/NCBI
13	Xu P, Zhao Y, Liu M, Wang Y, Wang H, Li YX, Zhu X, Yao Y, Wang H, Qiao J, et al: Variations of microRNAs in human placentas and plasma from preeclamptic pregnancy. Hypertension. 63:1276–1284. 2014. View Article : Google Scholar : PubMed/NCBI
14	Hromadnikova I, Kotlabova K, Hympanova L and Krofta L: Gestational hypertension, preeclampsia and intrauterine growth restriction induce dysregulation of cardiovascular and cerebrovascular disease associated microRNAs in maternal whole peripheral blood. Thromb Res. 137:126–140. 2016. View Article : Google Scholar : PubMed/NCBI
15	JR Jr, Alasztics B, Molvarec A, Nagy B and Biró O: 11 expression analysis of circulating exosomal hsa miR 210 in hypertensive disorders of pregnancy: Biomarkers, prediction of preeclampsia. Pregnancy Hypertens An Int J Wom Cardiovasc Health. 6:183. 2016.
16	Liu C, Zhou Y and Zhang Z: miR-210: An important player in the pathogenesis of preeclampsia? J Cell Mol Med. 16:943–944. 2012. View Article : Google Scholar : PubMed/NCBI
17	Tao J, Zhi X, Zhang X, Fu M, Huang H, Fan Y, Guan W and Zou C: miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer. J Exp Clin Cancer Res. 34:1392015. View Article : Google Scholar : PubMed/NCBI
18	Ruzzo A, Graziano F, Vincenzi B, Canestrari E, Perrone G, Galluccio N, Catalano V, Loupakis F, Rabitti C, Santini D, et al: High let-7a microRNA levels in KRAS-mutated colorectal carcinomas may rescue anti-EGFR therapy effects in patients with chemotherapy-refractory metastatic disease. Oncologist. 17:823–829. 2012. View Article : Google Scholar : PubMed/NCBI
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
20	Thongon N, Nakkrasae LI, Thongbunchoo J, Krishnamra N and Charoenphandhu N: Enhancement of calcium transport in Caco-2 monolayer through PKCzeta-dependent Cav1.3-mediated transcellular and rectifying paracellular pathways by prolactin. Am J Physiol Cell Physiol. 296:C1373–C1382. 2009. View Article : Google Scholar : PubMed/NCBI
21	Little R, Cartwright EJ, Neyses L and Austin C: Plasma membrane calcium ATPases (PMCAs) as potential targets for the treatment of essential hypertension. Pharmacol Ther. 159:23–34. 2016. View Article : Google Scholar : PubMed/NCBI
22	Gonçalves-Rizzi VH, Possomato-Vieira JS, Nascimento RA, Caldeira-Dias M and Dias-Junior CA: Maternal hypertension and feto-placental growth restriction is reversed by sildenafil: Evidence of independent effects of circulating nitric oxide levels. Eur J Pharmacol. 822:119–127. 2018. View Article : Google Scholar : PubMed/NCBI
23	Yan X, Yang Z, Chen Y, Li N, Wang L, Dou G, Liu Y, Duan J, Feng L, Deng S, et al: Endothelial cells-targeted soluble human Delta-like 4 suppresses both physiological and pathological ocular angiogenesis. Sci China Life Sci. 58:425–431. 2015. View Article : Google Scholar : PubMed/NCBI
24	Beltrame JS, Scotti L, Sordelli MS, Cañumil VA, Franchi AM, Parborell F and Ribeiro ML: Lysophosphatidic acid induces the crosstalk between the endovascular human trophoblast and endothelial cells in vitro. J Cell Physiol. 234:6274–6285. 2019. View Article : Google Scholar : PubMed/NCBI
25	Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA and McLaughlin MK: Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol. 161:1200–1204. 1989. View Article : Google Scholar : PubMed/NCBI
26	Huppertz B: Placental origins of preeclampsia: Challenging the current hypothesis. Hypertension. 51:970–975. 2008. View Article : Google Scholar : PubMed/NCBI
27	Brennan L, Morton JS, Quon A and Davidge ST: Postpartum vascular dysfunction in the reduced uteroplacental perfusion model of preeclampsia. PLoS One. 11:e01624872016. View Article : Google Scholar : PubMed/NCBI
28	Shen L, Diao Z, Sun HX, Yan GJ, Wang Z, Li RT, Dai Y, Wang J, Li J, Ding H, et al: Up-regulation of CD81 inhibits cytotrophoblast invasion and mediates maternal endothelial cell dysfunction in preeclampsia. Proc Natl Acad Sci USA. 114:1940–1945. 2017. View Article : Google Scholar : PubMed/NCBI
29	Granger JP, Alexander BT, Llinas MT, Bennett WA and Khalil RA: Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension. 38:718–722. 2001. View Article : Google Scholar : PubMed/NCBI
30	Sánchez-Aranguren LC, Prada CE, Riaño-Medina CE and Lopez M: Endothelial dysfunction and preeclampsia: Role of oxidative stress. Front Physiol. 5:3722014. View Article : Google Scholar : PubMed/NCBI
31	McDermott AM, Kerin MJ and Miller N: Identification and validation of miRNAs as endogenous controls for RQ-PCR in blood specimens for breast cancer studies. PLoS One. 8:e837182013. View Article : Google Scholar : PubMed/NCBI
32	Cengiz M, Karatas OF, Koparir E, Yavuzer S, Ali C, Yavuzer H, Kirat E, Karter Y and Ozen M: Differential expression of hypertension-associated microRNAs in the plasma of patients with white coat hypertension. Medicine (Baltimore). 94:e6932015. View Article : Google Scholar : PubMed/NCBI
33	Karolina DS, Tavintharan S, Armugam A, Sepramaniam S, Pek SLT, Wong MTK, Lim SC, Sum CF and Jeyaseelan K: Circulating miRNA profiles in patients with metabolic syndrome. J Clin Endocrinol Metab. 97:E2271–E2276. 2012. View Article : Google Scholar : PubMed/NCBI
34	Yang Q, Jia C, Wang P, Xiong M, Cui J, Li L, Wang W, Wu Q, Chen Y and Zhang T: MicroRNA-505 identified from patients with essential hypertension impairs endothelial cell migration and tube formation. Int J Cardiol. 177:925–934. 2014. View Article : Google Scholar : PubMed/NCBI
35	Yang Z, Xiao Z, Guo H, Fang X, Liang J, Zhu J, Yang J, Li H, Pan R, Yuan S, et al: Novel role of the clustered miR-23b-3p and miR-27b-3p in enhanced expression of fibrosis-associated genes by targeting TGFBR3 in atrial fibroblasts. J Cell Mol Med. 23:3246–3256. 2019. View Article : Google Scholar : PubMed/NCBI
36	Yu J, Lv Y, Wang F, Kong X, Di W, Liu J, Sheng Y, Lv S and Ding G: miR-27b-3p inhibition enhances browning of epididymal fat in high-fat diet induced obese mice. Front Endocrinol (Lausanne). 10:382019. View Article : Google Scholar : PubMed/NCBI
37	Lv X, Li J, Hu Y, Wang S, Yang C, Li C and Zhong G: Overexpression of miR-27b-3p targeting Wnt3a regulates the signaling pathway of Wnt/β-catenin and attenuates atrial fibrosis in rats with atrial fibrillation. Oxid Med Cell Longev. 2019:57037642019. View Article : Google Scholar : PubMed/NCBI
38	Liu Y, Cai Q, Bao PP, Su Y, Cai H, Wu J, Ye F, Guo X, Zheng W, Zheng Y, et al: Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes. Breast Cancer Res Treat. 152:183–191. 2015. View Article : Google Scholar : PubMed/NCBI
39	Chen D, Si W, Shen J, Du C, Lou W, Bao C, Zheng H, Pan J, Zhong G, Xu L, et al: miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells. Cell Death Dis. 9:1882018. View Article : Google Scholar : PubMed/NCBI
40	Song C, Yao J, Cao C, Liang X, Huang J, Han Z, Zhang Y, Qin G, Tao C, Li C, et al: PPARγ is regulated by miR-27b-3p negatively and plays an important role in porcine oocyte maturation. Biochem Biophys Res Commun. 479:224–230. 2016. View Article : Google Scholar : PubMed/NCBI
41	Xi B, Tang W and Wang Q: Polymorphism near the ATP2B1 gene is associated with hypertension risk in East Asians: A meta-analysis involving 15 909 cases and 18 529 controls. Blood Press. 21:134–138. 2012. View Article : Google Scholar : PubMed/NCBI
42	Drost JT, Maas AH, van Eyck J and van der Schouw YT: Preeclampsia as a female-specific risk factor for chronic hypertension. Maturitas. 67:321–326. 2010. View Article : Google Scholar : PubMed/NCBI
43	Sibai BM: Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 102:181–192. 2003. View Article : Google Scholar : PubMed/NCBI
44	Daily JW, Kim BC, Liu M and Park S: People with the major alleles of ATP2B1 rs17249754 increases the risk of hypertension in high ratio of sodium and potassium, and low calcium intakes. J Hum Hypertens. 31:787–794. 2017. View Article : Google Scholar : PubMed/NCBI
45	Ryan ZC, Craig TA, Filoteo AG, Westendorf JJ, Cartwright EJ, Neyses L, Strehler EE and Kumar R: Deletion of the intestinal plasma membrane calcium pump, isoform 1, Atp2b1, in mice is associated with decreased bone mineral density and impaired responsiveness to 1, 25-dihydroxyvitamin D3. Biochem Biophys Res Commun. 467:152–156. 2015. View Article : Google Scholar : PubMed/NCBI
46	Long Y, Chen SW, Gao CL, He XM, Liang GN, Wu J, Jiang CX, Liu X, Wang F and Chen F: ATP2B1 gene silencing increases NO production under basal conditions through the Ca²⁺/calmodulin/eNOS signaling pathway in endothelial cells. Hypertens Res. 41:246–252. 2018. View Article : Google Scholar : PubMed/NCBI
47	Zhang Y, Fei M, Xue G, Zhou Q, Jia Y, Li L, Xin H and Sun S: Elevated levels of hypoxia-inducible microRNA-210 in pre-eclampsia: New insights into molecular mechanisms for the disease. J Cell Mol Med. 16:249–259. 2012. View Article : Google Scholar : PubMed/NCBI
48	Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Alitalo K, Damsky C and Fisher SJ: Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol. 160:1405–1423. 2002. View Article : Google Scholar : PubMed/NCBI
49	Cross JC, Hemberger M, Lu Y, Nozaki T, Whiteley K, Masutani M and Adamson SL: Trophoblast functions, angiogenesis and remodeling of the maternal vasculature in the placenta. Mol Cell Endocrinol. 187:207–212. 2002. View Article : Google Scholar : PubMed/NCBI
50	Zhang M, Muralimanoharan S, Wortman AC and Mendelson CR: Primate-specific miR-515 family members inhibit key genes in human trophoblast differentiation and are upregulated in preeclampsia. Proc Natl Acad Sci USA:. 113:E7069–E7076. 2016. View Article : Google Scholar
51	Melincovici CS, Boşca AB, Şuşman S, Mărginean M, Mihu C, Istrate M, Moldovan IM, Roman AL and Mihu CM: Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. Rom J Morphol Embryol. 59:455–467. 2018.PubMed/NCBI
52	VanKlompenberg MK, Manjarín R, Donovan CE, Trott JF and Hovey RC: Regulation and localization of vascular endothelial growth factor within the mammary glands during the transition from late gestation to lactation. Domest Anim Endocrinol. 54:37–47. 2016. View Article : Google Scholar : PubMed/NCBI
53	Thangapazham RL, Sharma A, Gaddipati JP, Singh AK and Maheshwari RK: Inhibition of tumor angiogenesis by Brahma Rasayana (BR). J Exp Ther Oncol. 6:13–21. 2006.PubMed/NCBI
54	Zhong T, Chen J, Ling Y, Yang B, Xie X, Yu D, Zhang D, Ouyang J and Kuang H: Down-Regulation of neuropathy target esterase in preeclampsia placenta inhibits human trophoblast cell invasion via modulating MMP-9 levels. Cell Physiol Biochem. 45:1013–1022. 2018. View Article : Google Scholar : PubMed/NCBI
55	Lee DY, Deng Z, Wang CH and Yang BB: MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci USA. 104:20350–20355. 2007. View Article : Google Scholar : PubMed/NCBI
56	Shen X, Fang J, Lv X, Pei Z, Wang Y, Jiang S and Ding K: Heparin impairs angiogenesis through inhibition of microRNA-10b. J Biol Chem. 286:26616–26627. 2011. View Article : Google Scholar : PubMed/NCBI
57	Rong X, Ge D, Shen D, Chen X, Wang X, Zhang L, Jia C, Zeng J, He Y, Qiu H, et al: miR-27b suppresses endothelial cell proliferation and migration by targeting Smad7 in Kawasaki disease. Cell Physiol Biochem. 48:1804–1814. 2018. View Article : Google Scholar : PubMed/NCBI
58	Adu-Gyamfi EA, Fondjo LA, Owiredu WKBA, Czika A, Nelson W, Lamptey J, Wang YX and Ding YB: The role of adiponectin in placentation and preeclampsia. Cell Biochem Funct. 38:106–117. 2020. View Article : Google Scholar : PubMed/NCBI